BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7531094)

  • 1. [Alpha fetoprotein in congenital hypothyroidism before and during treatment].
    Toublanc JE; Ingrand J; Megarbane M; Fulla Y; Rives S
    Arch Pediatr; 1994 Oct; 1(10):872-8. PubMed ID: 7531094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphafetoprotein in screening for congenital hypothyroidism.
    Shawky RM; Abd el-Fattah S; el-din Azzam ME; Rafik MM; Osman A
    East Mediterr Health J; 2001; 7(1-2):171-80. PubMed ID: 12596967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital hypothyroidism. Therapeutic strategy at the early stage of treatment].
    Touati G; Léger J; Czernichow P
    Arch Fr Pediatr; 1991; 48(7):461-5. PubMed ID: 1929745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the ultrasensitive assay of plasma TSH for the surveillance of replacement treatment in children with congenital hypothyroidism].
    Raux Demay MC; Silvain A; Girard F
    Arch Fr Pediatr; 1988 Oct; 45(8):549-52. PubMed ID: 3214248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin screening for congenital hypothyroidism in Queen Sirikit National Institute of Child Health, Thailand (during year 1995-2000).
    Churesigaew S; Ratrisawasdi V; Thaeramanophab S
    J Med Assoc Thai; 2002 Jul; 85(7):782-8. PubMed ID: 12296410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-fetoprotein--a biochemical indicator of prenatal hypothyroidism.
    Larsson A; Hagenfeldt L; Blom L; Mortensson W
    Acta Paediatr Scand; 1983 Jul; 72(4):481-4. PubMed ID: 6194648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
    Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
    Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of congenital hypothyroidism. Study of 31,609 determinations].
    Tejedor JC; Omeñaca F; García Caballero C; Oliver A; Quero J; Peralta A; Morreale G; Escobar del Rey F
    An Esp Pediatr; 1983 May; 18(5):364-70. PubMed ID: 6614671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapeutic paradigm to treat congenital hypothyroidism.
    Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year thyrotropin screening for congenital hypothyroidism in Ramathibodi Hospital.
    Mahachoklertwattana P; Phuapradit W; Siripoonya P; Charoenpol O; Thuvasethakul P; Rajatanavin R
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S27-32. PubMed ID: 10730514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal screening for congenital hypothyroidism in West Black Sea area, Turkey.
    Simsek E; Karabay M; Kocabay K
    Int J Clin Pract; 2005 Mar; 59(3):336-41. PubMed ID: 15857333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
    Idris I; Srinivasan R; Simm A; Page RC
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):560-5. PubMed ID: 16268809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening programme for congenital hypothyroidism: preliminary results.
    Sadler WA; Lynskey C; Brownlie BE; Mortimer JG; Buckfield P; McArthur JE; Easton DM
    N Z Med J; 1979 Aug; 90(642):143-5. PubMed ID: 290922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
    Rana S; Nunlee-Bland G; Valyasevi R; Iqbal M
    Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of FT4 serum in newborns at risk for congenital hypothyroidism (CH).
    Cordova RA; Vignola G
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():152-3. PubMed ID: 15906723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.